EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Chikungunya: risks for travellers

Fabrice Simon, Eric Caumes, Tomas Jelinek, Rogelio Lopez-Velez, Robert Steffen, Lin H Chen

Journal of Travel Medicine · 05.04.2023 · 30 (2)

DOI: 10.1093/jtm/taad008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Travel Medicine, online erschienen am 16.01.2023. Verfasst von Fabrice Simon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pathologie Infectieuse et Tropicale, Hôpital d'Instruction des Armées Laveran, Marseille, France. Hauptthemen laut MEDLINE: Chikungunya Fever, Chikungunya virus, Aedes, Arthritis, Rheumatoid. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale for review Chikungunya outbreaks continue to occur, with changing epidemiology. Awareness about chikungunya is low both among the at-risk travellers and healthcare professionals, which can result in underdiagnosis and underreporting. This review aims to improve awareness among healthcare professionals regarding the risks of chikungunya for travellers. Key findings Chikungunya virus transmission to humans occurs mainly via daytime-active mosquitoes, Aedes aegypti and Aedes albopictus. The areas where these mosquitoes live is continuously expanding, partly due to climate changes. Chikungunya is characterized by an acute onset of fever with joint pain. These symptoms generally resolve within 1–3 weeks, but at least one-third of the patients suffer from debilitating rheumatologic symptoms for months to years. Large outbreaks in changing regions of the world since the turn of the 21st century (e.g. Caribbean, La Réunion; currently Brazil, India) have resulted in growing numbers of travellers importing chikungunya, mainly to Europe and North America. Viremic travellers with chikungunya infection have seeded chikungunya clusters (France, United States of America) and outbreaks (Italy in 2007 and 2017) in non-endemic countries where Ae. albopictus mosquitoes are present. Community preventive measures are important to prevent disease transmission by mosquitoes. Individual preventive options are limited to personal protection measures against mosquito bites, particularly the daytime-active mosquitos that transmit the chikungunya virus. Candidate vaccines are on the horizon and regulatory authorities will need to assess environmental and host risk factors for persistent sequelae, such as obesity, age (over 40 years) and history of arthritis or inflammatory rheumatologic disease to determine which populations should be targeted for these chikungunya vaccines. Conclusions/recommendations Travellers planning to visit destinations with active CHIKV circulation should be advised about the risk for chikungunya, prevention strategies, the disease manifestations, possible chronic rheumatologic sequelae and, if symptomatic, seek medical evaluation and report potential exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverChikungunya virusAedesArthritis, RheumatoidAnimalsHumansAdultEuropeFrance

Stichwörter der Autor:innen

AedesArbovirusepidemiologyinfectionmanagementpreventiontransmission

Autor:innen und Institutionen

  • Service de Pathologie Infectieuse et Tropicale, Hôpital d'Instruction des Armées Laveran, Marseille, France.
  • Centre de Diagnostic, Hôpital de l'Hôtel-Dieu, Paris, France.
  • Berlin Centre for Travel and Tropical Medicine, Berlin, Germany.
  • Ramón y Cajal Institute for Health Research (IRyCIS), Ramón y Cajal University Hospital, Madrid, Spain.
  • Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Center on Travelers' Health, University of Zurich, Zurich, Switzerland.
  • Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.

Zitieren

APA

Simon, F., Caumes, E., Jelinek, T., Lopez-Velez, R., Steffen, R., & Chen, L. H. (2023). Chikungunya: risks for travellers. Journal of Travel Medicine, 30(2). https://doi.org/10.1093/jtm/taad008

Vancouver

Simon F, Caumes E, Jelinek T, Lopez-Velez R, Steffen R, Chen LH. Chikungunya: risks for travellers. Journal of Travel Medicine. 2023;30(2). doi:10.1093/jtm/taad008

BibTeX
@article{Simon2023,
  author = {Simon, Fabrice and Caumes, Eric and Jelinek, Tomas and Lopez-Velez, Rogelio and Steffen, Robert and Chen, Lin H},
  title = {Chikungunya: risks for travellers},
  journal = {Journal of Travel Medicine},
  year = {2023},
  volume = {30},
  number = {2},
  doi = {10.1093/jtm/taad008}
}
Kostenlos starten →